Knowledge Distillery

The objective of this study was to report the prevalence of acute encephalopathy and outcomes in patients with severe COVID-19, and to identify…

Coronavirus disease 2019 (COVID-19), a global pandemic, has infected approximately 10% of the world's population. This comprehensive review aims to…

There is a paucity of nationally representative data regarding the impact of COVID-19 on acute ischemic stroke (AIS) outcome. In this article the…

There is increasing evidence of both central and peripheral nervous system (PNS) involvement in COVID-19. In this systematic literature review the…

COVID-19 infection can impact the central nervous system, and is often associated with cognitive decline. However, there are no studies linking…

86 patients with post-COVID syndrome (PCS) and 36 healthy controls with no exposure to SARS-CoV-2 were enrolled in the study. MRI imaging and…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). About 45% of COVID-19 patients experience…

Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy, often triggered by infection. The authors of this article aimed to…

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed "long COVID" or…

People with COVID-19 had poorer general cognitive functioning compared to people without COVID-19. The causal link between COVID-19 and cognitive…

Exceptional circumstances such as the COVID-19 pandemic increase the risk for vulnerability among people living with dementia. This article discusses…

Neurological manifestations are common in COVID-19, the disease caused by SARS-CoV-2. Despite reports of SARS-CoV-2 detection in the brain and…